Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Wave Life Sciences

    World Rank (Jan-05-2024)
    11,188
    Market Cap (Jan-05-2024)
    0.631 Billion USD
    World Rank (Jul-30-2023)
    14,083
    Market Cap (Jul-30-2023)
    0.403 Billion USD
    World Rank (Dec-25-2022)
    11,621
    Market Cap (Dec-25-2022)
    0.566 Billion USD
    World Rank (Jan-07-2022)
    19,803
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Singapore
    Stock Category
    Singapore ADRs
    Yahoo @ Nasdaq
    Company Website
    WAVE LIFE SCIENCES LTD.

  2. Altimmune

    World Rank (Jan-05-2024)
    11,225
    Market Cap (Jan-05-2024)
    0.628 Billion USD
    World Rank (Jul-30-2023)
    19,230
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    9,933
    Market Cap (Dec-25-2022)
    0.754 Billion USD
    World Rank (Jan-07-2022)
    16,056
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Net Income in USD
    -49 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    ALTIMMUNE

  3. MacroGenics Inc.

    World Rank (Jan-05-2024)
    11,264
    Market Cap (Jan-05-2024)
    0.623 Billion USD
    World Rank (Jul-30-2023)
    16,045
    Market Cap (Jul-30-2023)
    0.289 Billion USD
    World Rank (Dec-25-2022)
    14,480
    Market Cap (Dec-25-2022)
    0.365 Billion USD
    World Rank (Jan-07-2022)
    9,924
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -202 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    MacroGenics is a Clinical Stage Biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody based therapeutics for the treatment of cancer. The company annual revenue is 64 million USD and  307 employees as on 2019. The headquarters is in USA.
    Company Website
    MACROGENICS

  5. Evolus

    World Rank (Jan-05-2024)
    11,577
    Market Cap (Jan-05-2024)
    0.592 Billion USD
    World Rank (Jul-30-2023)
    11,861
    Market Cap (Jul-30-2023)
    0.577 Billion USD
    World Rank (Dec-25-2022)
    14,106
    Market Cap (Dec-25-2022)
    0.386 Billion USD
    World Rank (Jan-07-2022)
    15,668
    Market Cap (Jan-07-2022)
    0.35 Billion USD
    Annual Revenue in USD
    148 Million USD
    Annual Operating Income in USD
    -58 Million USD
    Annual Net Income in USD
    -74 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    EVOLUS

  6. Savara

    World Rank (Jan-05-2024)
    11,588
    Market Cap (Jan-05-2024)
    0.591 Billion USD
    World Rank (Jul-30-2023)
    13,226
    Market Cap (Jul-30-2023)
    0.464 Billion USD
    World Rank (Dec-25-2022)
    18,880
    Market Cap (Dec-25-2022)
    0.171 Billion USD
    World Rank (Jan-07-2022)
    20,538
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Website
    SAVARA

  7. Theravance Biopharma

    World Rank (Jan-05-2024)
    11,722
    Market Cap (Jan-05-2024)
    0.577 Billion USD
    World Rank (Jul-30-2023)
    11,975
    Market Cap (Jul-30-2023)
    0.565 Billion USD
    World Rank (Dec-25-2022)
    9,878
    Market Cap (Dec-25-2022)
    0.761 Billion USD
    World Rank (Jan-07-2022)
    9,685
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Headquarters Country
    Cayman Islands
    Yahoo @ Nasdaq
    Company Website
    THERAVANCE BIOPHARMA INC

  8. AN2 Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,747
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    19,243
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    18,440
    Market Cap (Dec-25-2022)
    0.185 Billion USD
    World Rank (Jan-07-2022)
    16,213
    Headquarters Country
    USA
    Company Profile

    AN2 Therapeutics, Inc is a biopharmaceutical company develops therapeutics to treat rare, chronic and serious infectious diseases in areas of high unmet medical need. The headquarters is in United States.

    Company Website
    AN2 THERAPEUTICS, INC.

  9. AnaptysBio Inc.

    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Net Income in USD
    -57 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
    Company Website
    ANAPTYSBIO INC

  10. Marinus Pharmaceuticals

    World Rank (Jan-05-2024)
    11,762
    Market Cap (Jan-05-2024)
    0.574 Billion USD
    World Rank (Jul-30-2023)
    12,607
    Market Cap (Jul-30-2023)
    0.512 Billion USD
    World Rank (Dec-25-2022)
    18,773
    Market Cap (Dec-25-2022)
    0.174 Billion USD
    World Rank (Jan-07-2022)
    14,722
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    25 Million USD
    Annual Operating Income in USD
    -112 Million USD
    Annual Net Income in USD
    -20 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Marinus Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an investigational drug, ganaxolone which is an innovative and much needed potential treatment option for children and adults. The company annual revenue is 1.72 million USD and 82 employees as on 2020. The headquarters is in USA.
    Company Website
    MARINUS PHARMACEUTICALS

Share